These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 13666753)
1. [Clinical use of strophanthin in the form of strophil]. HAGGENMILLER W; GESCHKE HJ Munch Med Wochenschr; 1959 May; 101(19):848-51. PubMed ID: 13666753 [No Abstract] [Full Text] [Related]
2. [Intravenous strophanthin therapy in heart diseases and its importance in general practice]. ASCHENBRENNER R Dtsch Med Wochenschr; 1956 Dec; 81(50):1988-91. PubMed ID: 13397271 [No Abstract] [Full Text] [Related]
4. [Influence of age on the effect of strophanthin in man]. MICHEL D; HARTLEB O; MARXHAUSEN E Z Klin Med; 1958; 155(3):288-309. PubMed ID: 13604588 [No Abstract] [Full Text] [Related]
5. [Problem of an increase of strophanthin effect by cocarboxylase]. MICHEL D; HARTLEB O Z Kreislaufforsch; 1959 Jun; 48(11-12):557-70. PubMed ID: 13676632 [No Abstract] [Full Text] [Related]
6. [Clinical studies on crataegutt-strophanthin & crataegutt]. IMMICH H Dtsch Med J; 1959 Jan; 10(2):39-42. PubMed ID: 13639731 [No Abstract] [Full Text] [Related]
7. [Clinical experiences with the combination preparation crataegutt-strophanthin]. SCHROER W Med Monatsschr; 1958 May; 12(5):312-4. PubMed ID: 13551873 [No Abstract] [Full Text] [Related]
8. [Miroton as adjuvant for the performance of ambulant strophanthin therapy after dismissal from the hospital & restored compensation]. ANGSTER H Medizinische; 1958 Jan; 2(2):90-2. PubMed ID: 13516220 [No Abstract] [Full Text] [Related]
9. [The indication of use of pandigal and strophanthin mixed injection]. STEINBERG H Med Klin; 1954 Jun; 49(23):927-8. PubMed ID: 13164985 [No Abstract] [Full Text] [Related]
10. [Theoretical-experimental and clinical fundamentals of peroral strophanthin therapy]. WIESEND W Ther Umsch; 1956 Sep; 13(9):172-6. PubMed ID: 13380794 [No Abstract] [Full Text] [Related]
11. Comparative efficiency of strophanthin preparations in cardiac disease. GOTTSEGEN G Ther Hung; 1954; 3():15-8. PubMed ID: 13247268 [No Abstract] [Full Text] [Related]
13. [Strophanthin K and P-aminobenzoate of diethylammonium in cardiotonic-sedative therapy]. LAMBERTI F Gazz Med Ital; 1954 Sep; 113(9):272-7. PubMed ID: 13232215 [No Abstract] [Full Text] [Related]
14. [Combined heart therapy with strophantin-theophylline]. BAUMANN C Med Klin; 1954 Aug; 49(34):1328-9. PubMed ID: 13203009 [No Abstract] [Full Text] [Related]
15. [Observations on the use of a new compound of nevanide and strophantin]. MUSCARI A; FOGLI M; DI MASSA R Gazz Med Ital; 1953 Dec; 112(12):328-31. PubMed ID: 13151376 [No Abstract] [Full Text] [Related]
16. [Application of cardiac drugs]. GOMORI P Orv Hetil; 1951 Mar; 92(13):403-13. PubMed ID: 13046847 [No Abstract] [Full Text] [Related]
17. [Strophanthin with calcium]. Lange G Z Allgemeinmed; 1970 Mar; 46(7):377. PubMed ID: 5442966 [No Abstract] [Full Text] [Related]
18. [Effect of strophanthin on the duration of phases of the heart cycle in patients with heart defects and circulatory disorders. (Based on electrokymographic data)]. Vebrova NN; Grugorian EA Klin Med (Mosk); 1966 Jan; 44(1):72-8. PubMed ID: 5984429 [No Abstract] [Full Text] [Related]
19. [Oral strophanthin therapy, especially in heart disease in aged]. WIESEND W Munch Med Wochenschr; 1956 Jun; 98(26):900-4. PubMed ID: 13348605 [No Abstract] [Full Text] [Related]
20. [Therapy of heart disease with khellin, with special reference to the khellinstrophanthin preparation strophokhelfren]. VON BLUMRODER WO Dtsch Med J; 1959 Apr; 10(6):176-9. PubMed ID: 13652721 [No Abstract] [Full Text] [Related] [Next] [New Search]